|
|
||||||||
The persistence of Trypanosoma cruzi in tissue and blood of 52 patients in the digestive form of chronic Chagas disease was studied. These patients had chagasic megaesophagus and underwent corrective surgery. Parasitologic (xenodiagnosis, hemoculture, or both), histopathologic (hematoxylin and eosin, and peroxidase-anti-peroxidase staining), and molecular (polymerase chain reaction [PCR] followed by slot-blot hybridization) tests were used in the analysis. The presence of T. cruzi, its genomic fragments, or its antigens could be detected in 98% (51 of 52) of the patients. The parasite was randomly identified in 76.9% of esophageal tissues and in 90.4% by PCR and in 73.1% by parasitologic methods from the blood. Fifty percent (26 of 52) of tissue samples had inflammation, 80.8% of which was associated with the parasite. Trypanosoma cruzi was also identified unassociated with inflammatory alterations. Higher tissue parasitism and intense inflammatory processes were observed in esophageal tissue from patients with Grade IV megaesophagus. These data demonstrate that in the digestive form of Chagas' disease, particularly in cases of megaesophagus, T. cruzi is frequently found, both in blood and tissues and may contribute to the pathogenic mechanisms involved.
This article has been cited by other articles:
![]() |
E. Lages-Silva, L. E. Ramirez, A. L. Pedrosa, E. Crema, L. M. da Cunha Galvao, S. D. Junho Pena, A. M. Macedo, and E. Chiari Variability of Kinetoplast DNA Gene Signatures of Trypanosoma cruzi II Strains from Patients with Different Clinical Forms of Chagas' Disease in Brazil. J. Clin. Microbiol., June 1, 2006; 44(6): 2167 - 2171. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Crema, L. B.P. Ribeiro, J. A. Terra Jr, and A. A. Silva Laparoscopic Transhiatal Subtotal Esophagectomy for the Treatment of Advanced Megaesophagus Ann. Thorac. Surg., October 1, 2005; 80(4): 1196 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. F. Meira, L. M. C. Galvao, E. D. Gontijo, G. L. L. Machado-Coelho, K. A. Norris, and E. Chiari Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients J. Clin. Microbiol., February 1, 2004; 42(2): 707 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. C. Galvao, E. Chiari, A. M. Macedo, A. O. Luquetti, S. A. Silva, and A. L. S. S. Andrade PCR Assay for Monitoring Trypanosoma cruzi Parasitemia in Childhood after Specific Chemotherapy J. Clin. Microbiol., November 1, 2003; 41(11): 5066 - 5070. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |